Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGM - Nasdaq Real Time Price USD

Longevity Health Holdings, Inc. (XAGE)

Compare
0.2560
-0.0018
(-0.70%)
At close: March 13 at 4:00:00 PM EDT
0.2251
-0.03
(-12.07%)
After hours: March 13 at 7:54:53 PM EDT
Loading Chart for XAGE
  • Previous Close 0.2578
  • Open 0.2500
  • Bid --
  • Ask --
  • Day's Range 0.2206 - 0.2690
  • 52 Week Range 0.1700 - 3.0000
  • Volume 687,144
  • Avg. Volume 8,101,555
  • Market Cap (intraday) 7.759M
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 0.53
  • EPS (TTM) 0.4800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Longevity Health Holdings, Inc. operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

www.carmellcosmetics.com

9

Full Time Employees

December 31

Fiscal Year Ends

Recent News: XAGE

View More

Performance Overview: XAGE

Trailing total returns as of 3/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 .

YTD Return

XAGE
8.24%
S&P 500
6.12%

1-Year Return

XAGE
89.06%
S&P 500
6.90%

3-Year Return

XAGE
97.35%
S&P 500
31.33%

5-Year Return

XAGE
97.45%
S&P 500
103.67%

Compare To: XAGE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: XAGE

View More

Valuation Measures

Annual
As of 3/13/2025
  • Market Cap

    7.71M

  • Enterprise Value

    7.36M

  • Trailing P/E

    0.53

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    171.54

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    223.97

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -6.39%

  • Return on Equity (ttm)

    -115.65%

  • Revenue (ttm)

    32.84k

  • Net Income Avi to Common (ttm)

    -9.75M

  • Diluted EPS (ttm)

    0.4800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.14M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    3.76M

Research Analysis: XAGE

View More

Company Insights: XAGE

Research Reports: XAGE

View More

People Also Watch